Thioredoxin-1 and MMP-9 as biomarkers in breast cancer metastasis in Egyptian female patients

References

• J.FerlayI.SoerjomataramR.DikshitS.EserC.MathersM.Rebeloet al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer13652015E359E386
   PubMed Web of Science ®Google Scholar
• K.ServickBreast cancer. Breast cancer: a world of differencesScience (New York, NY)3436178201414521453
   Google Scholar
• A.S.IbrahimH.M.KhaledN.N.MikhailH.BarakaH.KamelCancer incidence in Egypt: results of the national population-based cancer registry programJ Cancer Epidemiol20142014437971
   PubMedGoogle Scholar
• S.KimbungN.LomanI.HedenfalkClinical and molecular complexity of breast cancer metastasesSemin Cancer Biol3520158595
   PubMed Web of Science ®Google Scholar
• R.L.SiegelK.D.MillerA.JemalCancer statistics, 2015CA Cancer J Clin6512015529
   PubMed Web of Science ®Google Scholar
• A.R.NourazarianP.KangariA.SalmaninejadRoles of oxidative stress in the development and progression of breast cancerAsian Pac J Cancer Preven: APJCP1512201447454751
   Google Scholar
• I.S.HarrisA.E.TreloarS.InoueM.SasakiC.GorriniK.C.Leeet al.Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progressionCancer Cell2722015211222
   PubMed Web of Science ®Google Scholar
• B.J.ParkM.K.ChaI.H.KimThioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnosesBMC Res Notes720147
   PubMedGoogle Scholar
• A.HolmgrenThioredoxinAnnu Rev Biochem541985237271
   PubMed Web of Science ®Google Scholar
• S.G.RheeH.Z.ChaeK.KimPeroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signalingFree Radical Biol Med3812200515431552
   PubMed Web of Science ®Google Scholar
• M.BhatiaK.L.McGrathG.Di TrapaniP.CharoentongF.ShahM.M.Kinget al.The thioredoxin system in breast cancer cell invasion and migrationRedox Biol820166878
   PubMed Web of Science ®Google Scholar
• A.R.FarinaL.CappabiancaG.DeSantisN.Di IanniP.RuggeriM.Ragoneet al.Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cellsFEBS Lett58520201133283336
   Web of Science ®Google Scholar
• N.KilicM.Yavuz TaslipinarY.GuneyE.TekinE.OnukAn investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancerAnn Surg Oncol2113201441394143
   PubMed Web of Science ®Google Scholar
• C.MehnerA.HocklaE.MillerS.RanD.C.RadiskyE.S.RadiskyTumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancerOncotarget59201427362749
   PubMedGoogle Scholar
• J.M.SandL.LarsenC.HogaboamF.MartinezM.HanM.Rossel Larsenet al.MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis–validation of two novel biomarker assaysPLoS One8122013e84934
   Web of Science ®Google Scholar
• S.B.EdgeC.C.ComptonThe American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol176201014711474
   PubMed Web of Science ®Google Scholar
• T.YoshiokaK.KawadaT.ShimadaM.MoriLipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the bloodAm J Obstet Gynecol13531979372376
   PubMed Web of Science ®Google Scholar
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England). 2005;365 (9472):1687–717.
   Google Scholar
• R.MolinaV.BarakA.van DalenM.J.DuffyR.EinarssonM.Gionet al.Tumor markers in breast cancer- European group on tumor markers recommendationsTumour Biology: J Int Soc Oncodev Biol Med2662005281293
   PubMedGoogle Scholar
• B.GengM.M.LiangX.B.YeW.Y.ZhaoAssociation of CA 15–3 and CEA with clinicopathological parameters in patients with metastatic breast cancerMol Clin Oncol312015232236
   Web of Science ®Google Scholar
• I.J.FidlerCritical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lectureCancer Res5019199061306138
   PubMed Web of Science ®Google Scholar
• H.YamaguchiJ.WyckoffJ.CondeelisCell migration in tumorsCurr Opin Cell Biol1752005559564
   PubMed Web of Science ®Google Scholar
• D.T.LincolnE.M.Ali EmadiK.F.TonissenF.M.ClarkeThe thioredoxin-thioredoxin reductase system: over-expression in human cancerAnticancer Res233b200324252433
   Web of Science ®Google Scholar
• M.K.ChaK.H.SuhI.H.KimOverexpression of peroxiredoxin I and thioredoxin1 in human breast carcinomaJ Exp Clin Cancer Res: CR28200993
   PubMed Web of Science ®Google Scholar
• S.PatelG.SumitraB.C.KonerA.SaxenaRole of serum matrix metalloproteinase-2 and -9 to predict breast cancer progressionClin Biochem4410–112011869872
   Web of Science ®Google Scholar
• G.La RoccaI.Pucci-MinafraA.MarrazzoP.TaorminaS.MinafraZymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer seraBr J Cancer907200414141421
   Web of Science ®Google Scholar
• J.GaoX.LiuF.YangT.LiuQ.YanX.YangBy inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasisOncotarget62920152718727198
   Google Scholar
• J.LiJ.ZhangY.WangX.LiangZ.WusimanY.Yinet al.Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathwayInt J Pharm52312017300309
   PubMed Web of Science ®Google Scholar
• Y.A.RashadT.R.ElkhodaryA.M.El-GayarL.A.EissaEvaluation of serum levels of HER2, MMP-9, nitric oxide, and total antioxidant capacity in Egyptian breast cancer patients: correlation with clinico-pathological parametersSci Pharm8212014129145
   Google Scholar
• J.ZhangL.YinJ.WuY.ZhangT.XuR.Maet al.Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinomaExp Ther Med812014175180
   Web of Science ®Google Scholar
• D.S.HeoH.ChoiM.Y.YeomB.J.SongS.J.OhSerum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patientsOncol Rep314201415671572
   PubMed Web of Science ®Google Scholar
• A.DanieleA.F.ZitoG.GiannelliR.DivellaM.AsseltiA.Mazzoccaet al.Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancerAnticancer Res309201035213527
   Web of Science ®Google Scholar
• J.H.ParkY.Y.ChoS.W.YoonB.ParkSuppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-kappaB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cellsInt J Oncol493201612301240
   Web of Science ®Google Scholar
• S.SinhaS.KhanS.ShuklaA.D.LakraS.KumarG.Daset al.Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axisInt J Biochem Cell Biol7720164156 Pt A
   Web of Science ®Google Scholar
• Wang M, Dhingra K, Hittelman WN, Liehr JG, de Andrade M, Li D. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1996;5(9):705–10
   Google Scholar
• A.Sadati ZarriniD.MoslemiH.ParsianM.VessalA.MosapourKelagari Z.ShirkhaniThe status of antioxidants, malondialdehyde and some trace elements in serum of patients with breast cancerCaspian J Internal Med7120163136
   Web of Science ®Google Scholar
• C.P.RajneeshA.ManimaranK.R.SasikalaP.AdaikappanLipid peroxidation and antioxidant status in patients with breast cancerSingapore Med J4982008640643
   Web of Science ®Google Scholar
• C.C.YehM.F.HouS.M.TsaiS.K.LinJ.K.HsiaoJ.C.Huanget al.Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancerClin Chim Acta; Int J Clin Chem3611–22005104111
   PubMed Web of Science ®Google Scholar
• A.GonencY.OzkanM.TorunB.SimsekPlasma malondialdehyde (MDA) levels in breast and lung cancer patientsJ Clin Pharm Ther2622001141144
   PubMed Web of Science ®Google Scholar
• D.PandeR.NegiS.KhannaR.KhannaH.D.KhannaVascular endothelial growth factor levels in relation to oxidative damage and antioxidant status in patients with breast cancerJ Breast Cancer1432011181184
   Web of Science ®Google Scholar
• D.BaskicS.PopovicD.BankovicA.ArsovicV.VukovicI.Zelenet al.Evaluation of inflammatory biomarkers as helping diagnostic tool in patients with breast cancerCancer Biomarkers: Sec A Dis Markers1462014401408
   Web of Science ®Google Scholar
• A.GonencD.TokgozS.AslanM.TorunOxidative stress in relation to lipid profiles in different stages of breast cancerIndian J Biochem Biophys4232005190194
   Web of Science ®Google Scholar